Literature DB >> 6415488

Expression-cloning and sequence of a cDNA encoding human growth hormone-releasing factor.

K E Mayo, W Vale, J Rivier, M G Rosenfeld, R M Evans.   

Abstract

Growth hormone-releasing factor (GRF) is believed to mediate both neural and hormonal control of the release and perhaps synthesis of growth hormone (GH) from the anterior pituitary. Its presence in only minute quantities in the hypothalamus hampered for many years efforts to determine its structure. Recently, two groups independently characterized a peptide from two human pancreatic tumours that possessed GH-releasing activity. Antibodies to this peptide have revealed immunoreactive material in the hypothalamus of several primate species. Furthermore, an apparently identical peptide has now been isolated directly from human hypothalamus. Using both oligonucleotide and antibody screening of a cDNA expression library, we have isolated a recombinant clone encoding human pancreatic GRF (hpGRF) within a larger precursor protein. The nucleotide sequence predicts that processing of GRF from the precursor should generate two additional peptides of unknown function. Restriction analysis of genomic DNA indicates that there is probably a single human GRF gene and suggests that the pancreatic tumour and hypothalamic proteins are encoded by an identical mRNA.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6415488     DOI: 10.1038/306086a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  27 in total

Review 1.  A history of acromegaly.

Authors:  R Sheaves
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

2.  Immunoreactive neuronal pathways of growth hormone-releasing hormone (GRH) in the brain and pituitary of the teleost Gadus morhua.

Authors:  J X Pan; R M Lechan; H D Lin; I M Jackson
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

Review 3.  Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies.

Authors:  Megan C Chapter; Caitlin M White; Angela DeRidder; Wayne Chadwick; Bronwen Martin; Stuart Maudsley
Journal:  Pharmacol Ther       Date:  2009-08-15       Impact factor: 12.310

Review 4.  Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications.

Authors:  G Delitala; P Tomasi; R Virdis
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256

5.  Processing of prosecretin: isolation of a secretin precursor from porcine intestine.

Authors:  G Gafvelin; H Jörnvall; V Mutt
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

6.  Isolation of the gene and hypothalamic cDNA for the common precursor of gonadotropin-releasing hormone and prolactin release-inhibiting factor in human and rat.

Authors:  J P Adelman; A J Mason; J S Hayflick; P H Seeburg
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

7.  Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor.

Authors:  N Ling; F Esch; P Böhlen; P Brazeau; W B Wehrenberg; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

8.  Circulating growth hormone releasing factor concentrations in normal subjects and patients with acromegaly.

Authors:  E S Penny; E Penman; J Price; L H Rees; A M Sopwith; J A Wass; N Lytras; G M Besser
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-25

9.  The serendipitous origin of chordate secretin peptide family members.

Authors:  João C R Cardoso; Florbela A Vieira; Ana S Gomes; Deborah M Power
Journal:  BMC Evol Biol       Date:  2010-05-06       Impact factor: 3.260

10.  Vasopressin mRNA in situ hybridization: localization and regulation studied with oligonucleotide cDNA probes in normal and Brattleboro rat hypothalamus.

Authors:  G R Uhl; H H Zingg; J F Habener
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.